MetLife (MET) and Prudential Financial (PRU) are two of the largest life insurance and financial-services franchises in the United States, each with substantial international operations. Investors and traders comparing these two names are typically evaluating similar questions: which company offers stronger earnings momentum, more consistent capital returns, and a more favorable risk-reward profile in the current market environment. Because both stocks respond to overlapping drivers—interest rates, underwriting results, investment income, and currency moves—this stock comparison is especially relevant for those weighing two established financial-sector leaders with distinct strategic trajectories and near-term catalysts.
MetLife is one of the largest U.S. life insurers by assets, organized across Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa, and its MetLife Holdings run-off segment. In recent market activity, MET has drawn attention for a strengthening investment-management platform: its acquisition of PineBridge Investments closed late in the reporting period, expanding the firm's assets under management (AUM) and adding fee-based revenue diversification. Management has also signaled disciplined capital deployment, planning roughly $2.85 billion in share repurchases for the year and targeting double-digit adjusted earnings growth with an adjusted return on equity (ROE) in the mid-teens range. These catalysts, together with a resilient U.S. group benefits franchise, have supported relatively firm sentiment in recent weeks.
Prudential Financial provides retirement strategies, group insurance, individual life products, and investment management through its PGIM arm, which oversees roughly $1.5 trillion in assets under management. PRU delivered solid full-year earnings growth, with quarterly results improving from a prior-year loss to a profit, and its U.S. retirement and group businesses posted stronger spread income and underwriting. However, recent performance has been tempered by two notable headwinds: a voluntary 90-day suspension of new sales in Prudential of Japan following internal findings of employee misconduct, and continued client outflows in parts of its active asset-management business amid the broader industry shift toward passive strategies. The company also authorized up to $1 billion in buybacks and raised its dividend for an 18th consecutive year, underscoring continued capital discipline.
Tickeron's Trending AI Robots page highlights a curated selection of the platform's automated trading strategies. Tickeron maintains hundreds of AI trading bots that collectively trade thousands of different tickers, but only the strongest performers suited to current market conditions earn a place in this featured section. These bots vary widely in trading style, strategy, timeframe, performance statistics, and the specific tickers they follow, giving users a broad view of how algorithmic systems are positioning across sectors. For traders interested in how automated, data-driven systems are navigating names like MET and PRU, the Trending AI Robots section offers a practical starting point to explore strategies currently gaining traction.
The two companies diverge most clearly on recent catalysts and risk concentration. MET is executing an expansion of its asset-management capabilities, which could add a more stable, fee-driven earnings stream and reduce reliance on spread income. PRU, by contrast, is in remediation mode in Japan while simultaneously managing outflows at PGIM, even as its U.S. retirement franchise performs well. On capital returns, both firms are aggressive buyers of their own stock, but the near-term earnings path appears more consistent for MET. From a sector-exposure standpoint, both carry meaningful sensitivity to interest rates, credit, and currency, yet their international footprints differ—MetLife leans more heavily on Latin America alongside Asia, while Prudential's international income is concentrated in Japan and, increasingly, Brazil.
Weighing trend consistency, earnings stability, and forward catalysts, the AI-driven framework would likely favor MET in the current environment. The rationale rests on observable factors: a comparatively cleaner near-term setup, an accretive and diversifying acquisition, and a steadier capital-return narrative. PRU retains structural strengths in retirement and insurance, but its Japan remediation and asset-management outflows introduce a degree of uncertainty that is not yet reflected in a clear trend signal. This assessment is probabilistic rather than definitive, and relative positioning could shift as new earnings and remediation updates emerge.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 228 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on MET as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 04, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 32 of 52 cases over the following month. The odds of a continued upward trend are 62%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 156 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 25 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.383) is slightly higher than the industry average of (1.352). P/E Ratio (19.561) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The 10-day moving average for PRU crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on PRU as a result. In 56 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for PRU just turned positive on October 15, 2026. Looking at past instances where PRU's MACD turned positive, the stock continued to rise in 28 of 45 cases over the following month. The odds of a continued upward trend are 62%.
PRU moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRU advanced for three days, in 209 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
PRU broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PRU entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. PRU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.384) is normal, around the industry mean (1.352). P/E Ratio (11.418) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (0.674) is also within normal values, averaging (0.463). Dividend Yield (0.044) settles around the average of (0.047) among similar stocks. P/S Ratio (0.632) is also within normal values, averaging (1.303).
The Tickeron Profit vs. Risk Rating rating for this company is 35 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
MET | PRU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 37 | 38 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 20 | 35 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 19 | 29 | |
P/E GROWTH RATING 1..100 | 12 | 77 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PRU's Valuation (30) in the Financial Conglomerates industry is in the same range as MET (56) in the Life Or Health Insurance industry. This means that PRU’s stock grew similarly to MET’s over the last 12 months.
MET's Profit vs Risk Rating (20) in the Life Or Health Insurance industry is in the same range as PRU (35) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as PRU (100) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's Price Growth Rating (19) in the Life Or Health Insurance industry is in the same range as PRU (29) in the Financial Conglomerates industry. This means that MET’s stock grew similarly to PRU’s over the last 12 months.
MET's P/E Growth Rating (12) in the Life Or Health Insurance industry is somewhat better than the same rating for PRU (77) in the Financial Conglomerates industry. This means that MET’s stock grew somewhat faster than PRU’s over the last 12 months.
| MET | PRU | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 53% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 51% |
| Momentum ODDS (%) | 2 days ago 57% | 2 days ago 61% |
| MACD ODDS (%) | 2 days ago 62% | 2 days ago 62% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 58% |
| Advances ODDS (%) | 2 days ago 66% | 2 days ago 59% |
| Declines ODDS (%) | 9 days ago 51% | 18 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 51% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 61% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while PRU’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 6 TA indicator(s) are bullish while PRU’s TA Score has 5 bullish TA indicator(s).
MET (@Life/Health Insurance) experienced а +3.87% price change this week, while PRU (@Life/Health Insurance) price change was +9.76% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.53%. For the same industry, the average monthly price growth was -1.47%, and the average quarterly price growth was -4.10%.
MET is expected to report earnings on Feb 03, 2027.
PRU is expected to report earnings on Feb 09, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
A.I.dvisor indicates that over the last year, PRU has been closely correlated with MET. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRU jumps, then MET could also see price increases.